CHINA Homegrown COVID-19 pill gets regulatory approval


Homegrown COVID-19 pill gets regulatory approval

China Daily

22:11, July 25, 2022

China's top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19.

File photo: Sohu

Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration.

The approval clears the way for the pill to be used for adults with moderate COVID-19 symptoms, the administration said in a notice released on its official website.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue